Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

Antolín Novoa, Silvia
Thumbnail
Estatísticas
Estatísticas
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/7625
PMID: 21717449
ISSN: 0008-543X
Rexistro completo
Servizos
Servizos
RISMendeleyLinksolver
Data de publicación
2012
Título da revista
CANCER
Tipo de contido
Artigo